A national survey of the treatment of hyperlipidemia in primary prevention

JAMA Intern Med. 2013 Apr 8;173(7):586-8; discussion 588. doi: 10.1001/jamainternmed.2013.2797.
No abstract available

Publication types

  • Letter

MeSH terms

  • Data Collection
  • Decision Making
  • Drug Prescriptions
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Hyperlipidemias / prevention & control*
  • Risk Assessment
  • United States

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors